These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 10625595)
1. Evaluating peptide repertoires within the context of thymocyte development. Barton GM; Rudensky AY Semin Immunol; 1999 Dec; 11(6):417-22. PubMed ID: 10625595 [TBL] [Abstract][Full Text] [Related]
2. The nature of the peptide/MHC ligand involved in positive selection. Hogquist KA; Bevan MJ Semin Immunol; 1996 Apr; 8(2):63-8. PubMed ID: 8920241 [TBL] [Abstract][Full Text] [Related]
3. Immune selection in murine tumors. Ph.d thesis. Svane IM; Engel AM APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251 [TBL] [Abstract][Full Text] [Related]
4. How the T cell repertoire becomes peptide and MHC specific. Huseby ES; White J; Crawford F; Vass T; Becker D; Pinilla C; Marrack P; Kappler JW Cell; 2005 Jul; 122(2):247-60. PubMed ID: 16051149 [TBL] [Abstract][Full Text] [Related]
5. Thymic T-cell tolerance of neuroendocrine functions: physiology and pathophysiology. Geenen V; Kecha O; Brilot F; Hansenne I; Renard C; Martens H Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):179-88. PubMed ID: 11292253 [TBL] [Abstract][Full Text] [Related]
6. Interaction of peptide antigens and class II major histocompatibility complex antigens. Guillet JG; Lai MZ; Briner TJ; Smith JA; Gefter ML Nature; 1986 Nov 20-26; 324(6094):260-2. PubMed ID: 2946957 [TBL] [Abstract][Full Text] [Related]
8. In vivo MHC class II presentation of cytosolic proteins revealed by rapid automated tandem mass spectrometry and functional analyses. Dongre AR; Kovats S; deRoos P; McCormack AL; Nakagawa T; Paharkova-Vatchkova V; Eng J; Caldwell H; Yates JR; Rudensky AY Eur J Immunol; 2001 May; 31(5):1485-94. PubMed ID: 11465105 [TBL] [Abstract][Full Text] [Related]
9. MHC class I antigen presentation--recently trimmed and well presented. Flutter B; Gao B Cell Mol Immunol; 2004 Feb; 1(1):22-30. PubMed ID: 16212917 [TBL] [Abstract][Full Text] [Related]
10. Unraveling a revealing paradox: Why major histocompatibility complex I-signaled thymocytes "paradoxically" appear as CD4+8lo transitional cells during positive selection of CD8+ T cells. Bosselut R; Guinter TI; Sharrow SO; Singer A J Exp Med; 2003 Jun; 197(12):1709-19. PubMed ID: 12810689 [TBL] [Abstract][Full Text] [Related]
11. Direct identification of human tumor-associated peptide antigens and a preclinical model to evaluate their use. Engelhard VH; Bullock TN; Colella TA; Mullins DW Cancer J; 2000 May; 6 Suppl 3():S272-80. PubMed ID: 10874498 [TBL] [Abstract][Full Text] [Related]
12. Induction of central T cell tolerance: recombinant antibodies deliver peptides for deletion of antigen-specific (CD4+)8+ thymocytes. Schjetne KW; Thommesen JE; Fredriksen AB; Lunde E; Sandlie I; Bogen B Eur J Immunol; 2005 Nov; 35(11):3142-52. PubMed ID: 16184515 [TBL] [Abstract][Full Text] [Related]
13. Antigen processing: a critical factor in rational vaccine design. Yewdell JW; Bennink JR Semin Hematol; 1993 Oct; 30(4 Suppl 4):26-32; discussion 33-4. PubMed ID: 8303307 [TBL] [Abstract][Full Text] [Related]
14. T-T interaction during thymic selection. Choi EY; Bae Y; Lee DS; Park SH Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):135-43. PubMed ID: 11292248 [TBL] [Abstract][Full Text] [Related]